Skip to main content Accessibility help

The Challenges of Carbapenemase-Producing Enterobacteriaceae and Infection Prevention: Protecting Patients in the Chaos

  • Patrice Savard (a1), Karen C. Carroll (a2), Lucy E. Wilson (a3) and Trish M. Perl (a1)


  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.


Corresponding author

Epidemiology and Infection Prevention, The Johns Hopkins Health System, 327 A Billings Building, Johns Hopkins Hospital, 1800 Orleans Street, Baltimore, MD 21287 (


Hide All
1.Bush, K, Jacoby, GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother Mar 2010;54(3):969976.
2.Knothe, H, Shah, P, Krcmery, V, Antal, M, Mitsuhashi, S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and ce-furoxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11(6):315317.
3.Paterson, DL, Bonomo, RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005;18(4):657686.
4.Philippon, A, Labia, R, Jacoby, G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989;33(8):11311136.
5.Bartlett, JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis 2011;53(suppl 1):S4S7.
6.Queenan, AM, Bush, K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007;20(3):440458.
7.Yigit, H, Queenan, AM, Anderson, GJ, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45(4):11511161.
8.Arnold, RS, Thom, KA, Sharma, S, Phillips, M, Johnson, JK, Morgan, DJ. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J 2011;104(1):4045.
9.Cornaglia, G, Giamarellou, H, Rossolini, GM. Metallo-β-lacta-mases: a last frontier for β-lactams? Lancet Infect Dis 2011;11(5): 381393.
10.Kumarasamy, KK, Toleman, MA, Walsh, TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10(9):597602.
11.Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep 2009;58(10):256260.
12.World Health Organization. The evolving threat of antimicrobial resistance: options for action,
13.Savard, P, Perl, TM. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings. Curr Opin Infect Dis 2012;25(4):371377.
14.Kallen, AJ, Srinivasan, A. Current epidemiology of multidrug-resistant gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 2010;31(suppl 1):S51S54.
15.Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae. epidemiology and prevention. Clin Infect Dis 2011;53(1):6067.
16.Cagnacci, S, Gualco, L, Roveta, S, et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J Antimicrob Chemother 2008;61(2):296300.
17.Tato, M, Coque, TM, Ruiz-Garbajosa, P, et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β-lactamase in Spain: toward endemicity? Clin Infect Dis 2007;45(9):11711178.
18.Vatopoulos, A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece: a review of the current evidence. Euro Surveill 2008;13(4):pii = 8023.
19.Canton, R, Akova, M, Carmeli, Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012;18(5):413431.
20.Prior, AR, Roche, C, Lynch, M, Kelly, S, O'Rourke, K, Crowley, B. First identified case of VIM-producing carbapenem-resistant Klebsiella pneumoniae in the Republic of Ireland associated with fatal outcome. Euro Surveill 2010;15(50):pii= 19752.
21.Samuelsen, Ø, Toleman, MA, Hasseltvedt, V, et al. Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect 2011;17(11):18111816.
22.Kristóf, K, Tóth, Á, Damjanova, I, et al. Identification of bla VIM-4 gene in the internationally successful Klebsiella pneumoniae STI 1 clone and in a Klebsiella oxytoca strain in Hungary. J Antimicrob Chemother 2010;65(6):13031305.
23.Montealegre, MC, Correa, A, Briceño, DF, et al. Novel VIM met-allo-β-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia. Antimicrob Agents Chemother 2011;55(5):24282430.
24.Centers for Disease Control and Prevention. Update: detection of a Verona integron-encoded metallo-beta-lactamase in Klebsiella pneumoniae-United States, 2010. Morb Mortal Wkly Rep 2010;59(37):1212.
25.Limbago, BM, Rasheed, JK, Anderson, KF, et al. IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J Clin Microbiol 2011;49(12):42394245.
26.Struelens, MJ, Monnet, DL, Magiorakos, AP, Santos O'Connor, F, Giesecke, J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010;15(46):pii= 19716.
27.Perry, JD, Naqvi, SH, Mirza, IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 2011;66(10):22882294.
28.Rolain, JM, Parola, P, Cornaglia, G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect 2010;16(12):16991701.
29.Nordmann, P, Poirel, L, Walsh, TR, Livermore, DM. The emerging NDM carbapenemases. Trends Microbiol 2011;19(12):588595.
30.Walsh, TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010;36(suppl 3):S8S14.
31.Poirel, L, Lagrutta, E, Taylor, P, Pham, J, Nordmann, P. Emergence of metallo-/β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010;54(11):49144916.
32.Tijet, N, Alexander, DC, Richardson, D, et al. New Delhi metallo-β-lactamase, Ontario, Canada. Emerg infect Dis 2011;17(2):306307.
33.Centers for Disease Control and Prevention. Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients-Rhode Island, March 2012. Morb Mortal Wkly Rep 2012;61(24):446448.
34.Savard, P, Gopinath, R, Zhu, W, et al. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 2011;55(12):59575958.
35.Centers for Disease Control and Prevention. Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase- United States, 2010 Morb Mortal Wkly Rep 2010;59(24):750.
36.Mochon, AB, Garner, OB, Hindier, JA, et al. New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol 2011;49(4): 16671670.
37.Poirel, L, Lagrutta, E, Taylor, P, Pham, J, Nordmann, P. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010;54(11):49144916.
38.Gregory, CJ, Llata, E, Stine, N, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010;31(5):476484.
39.Poirel, L, Hervé, V, Hombrouck-Alet, C, Nordmann, P. Long-term carriage of NDM-1-producing Escherichia coli. J Antimicrob Chemother 2011;66(9):21852186.
40.Nordmann, P, Cuzon, G, Naas, T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9(4):228236.
41.Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):10991106.
42.Souli, M, Galani, I, Antoniadou, A, et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010;50(3):364373.
43.Livermore, D, Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection. Advice on carbapenemase producers: recognition, infection control and treatment. Health Protection Agency website, Published 2011.
44.Public Health Agency of Canada. Guidance: infection prevention and control measures for healthcare workers in all healthcare settings. Carbapenem-resistant gram-negative bacilli, Published 2010.
45.CINQ (Comité sur les infections nosocomiales du Québec). Avis et recommandations: prévention et contrôle de la transmission des entérobactéries productrices de carbapénémases dans les milieux de soins aigus du Québec. Institut National de Santé Publique du Québec website, Published October 2010.
46.Haut Conseil de la santé publique. Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques importées en France par des patients rapatriés ou ayant des antécédents d'hospitalisation à l'étranger. 2nd version, Published November 2010.
47.Carmeli, Y, Akova, M, Cornaglia, G, et al. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16(2): 102111.
48.Grundmann, H, Livermore, DM, Giske, CG, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010;15(46): pii= 19711.
49.Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2012 CRE toolkit. Updated March 5, 2013.
50.Kollef, MH, Golan, Y, Micek, ST, Shorr, AF, Restrepo, MI. Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections: proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis 2011;53(suppl 2):S33S58.
51.Wendt, C, Schütt, S, Dalpke, AH, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010;29(5):563570.
52.Doern, CD, Dunne, WM Jr, Burnham, CA. Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. J Clin Microbiol 2011;49(3): 11431147.
53.Clinical and Laboratory Standards Institute (CLSI). 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement (June 2010 update). Wayne, PA: CLSI, 2010. CLSI document M100-S20-U.
54.Pasteran, F, Lucero, C, Soloaga, R, Rapoport, M, Corso, A. Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae? J Clin Microbiol 2011;49(2):697701.
55.Seah, C, Low, DE, Patel, SN, Melano, RG. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol 2011;49(5):19651969.
56.Girlich, D, Poirel, L, Nordmann, P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012;50(2):477479.
57.Nordmann, P, Girlich, D, Poirel, L. Detection of carbapenemase producers in Enterobacteriaceae using a novel screening medium. J Clin Microbiol 2012;50:(8):27612766.
58.Vrioni, G, Daniii, I, Voulgari, E, et al. Comparative evaluation of a prototype chromogenic medium (chromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs. J Clin Microbiol 2012;50(6):18411846.
59.Wilkinson, KM, Winstanley, TG, Lanyon, C, Cummings, SP, Raza, MW, Perry, JD. Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2012;50(9):31023104.
60.Siegel, JD, Rhinehart, E, Jackson, M, et al. Management of multidrug-resistant organisms in healthcare settings, 2006. Healthcare Infection Control Practices Advisory Committee (HICPAC) website, Updated December 29, 2009.
61.Won, SY, Munoz-Price, LS, Lolans, K, Hota, B, Weinstein, RA, Hayden, MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53(6):532540.
62.Marchaim, D, Chopra, T, Bogan, C, et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control 2012;40(8):760765.
63.Tamma, PD, Savard, P, Pal, T, Sonnevend, A, Perl, TM, Milstone, AM. An outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2012;33(6):631634.
64.Munoz-Price, LS, Hayden, MK, Lolans, K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31(4):341347.
65.Naas, T, Cuzon, G, Babies, A, et al. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 β-lactamase. J Antimicrob Chemother 2010;65(6): 13051306.
66.Carbonne, A, Thiolet, JM, Fournier, S, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010;15(48):pii= 19734.
67.Schechner, V, Kotlovsky, T, Tarabeia, J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011;32(5):497503.
68.Passaretti, CL, Otter, JA, Reich, NG, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2013;56(1):2735.
69.Lee, BY, Bartsch, SM, Wong, KF, et al. Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone. Health Aff 2012;31(10):22952303.
70.Akova, M, Daikos, GL, Tzouvelekis, L, Carmeli, Y. Interventional strategies and current clinical experience with carbapenemase-producing gram-negative bacteria. Clin Microbiol Infect 2012;18(5):439448.
71.Schechner, V, Kotlovsky, T, Kazma, M, et al. Asymptomatic rectal carriage of bla KPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2013;19(5):451456.
72.Rapp, RP, Urban, C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy 2012;32(5):399407.
73.Livermore, DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012;27(2): 128142.

The Challenges of Carbapenemase-Producing Enterobacteriaceae and Infection Prevention: Protecting Patients in the Chaos

  • Patrice Savard (a1), Karen C. Carroll (a2), Lucy E. Wilson (a3) and Trish M. Perl (a1)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed